Skip to content
Boost Up Blog – Lifestyle
Author:
Spero Therapeutics, Inc.
Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
June 17, 2026
Spero Therapeutics Announces First Quarter 2026 Operating Results and Provides Business Update
May 21, 2026
Spero Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026
May 5, 2026
Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 26, 2026
March 18, 2026